wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38816700-51E7EF9D-5338-46C5-820F-8F10D5DA46B7
Q38816700-51E7EF9D-5338-46C5-820F-8F10D5DA46B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38816700-51E7EF9D-5338-46C5-820F-8F10D5DA46B7
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice.
P2860
Q38816700-51E7EF9D-5338-46C5-820F-8F10D5DA46B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38816700-51E7EF9D-5338-46C5-820F-8F10D5DA46B7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8ed99a262419342e9138bf74a027db356440a035
P2860
Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib.